Learning Objectives:

  1. Should we consider continuing or adding cilostazol after endovascular revascularization of femoropopliteal peripheral arterial disease? 
  2. Review efficacy and effects of IVUS in endovascular interventions in PAD.
  3. Review secondary endpoint of reintervention in patients enrolled in the BEST CLI  who underwent open or endovascular revascularization. 

 

Session date: 
12/12/2024 - 7:30am to 8:30am CST
Add to calendar: 
  • 1.00 ABS Accredited CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Meghan Barber, MD